TY - JOUR
T1 - Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021
AU - Loftus, Michael J.
AU - Everts, Richard J.
AU - Cheng, Allen C.
AU - Eti, Perenise
AU - Fakasiieiki, Timote
AU - Isaia, Lupeoletalelei
AU - Isopo, Enita
AU - Jenney, Adam W.J.
AU - Lameko, Viali
AU - Leaupepe, Hinauri
AU - Leavai, Folototo
AU - Lee, Sue J.
AU - Moungaevalu, Mele
AU - Stewardson, Andrew J.
AU - Tekoaua, Rosemary
AU - Tou, Douglas
AU - Wuatai, Geoffrey
AU - Peleg, Anton Y.
N1 - Funding Information:
Supported by the National Health and Medical Research Council.We gratefully acknowledge the assistance of Dr Iain Abbott (Alfred Hospital and Monash University, Australia) for his critical review, and Mr Navin Karan (Pacific Pathology Training Centre, New Zealand) for his assistance providing quality assurance data. Funding: MJL, AJS, and AYP are supported by Australian National Health and Medical Research Council Postgraduate Scholarship (APP1169220), Early Career Fellowship (GNT1141398) and Practitioner Fellowship (APP1117940), respectively.
Funding Information:
Funding: MJL, AJS, and AYP are supported by Australian National Health and Medical Research Council Postgraduate Scholarship ( APP1169220 ), Early Career Fellowship ( GNT1141398 ) and Practitioner Fellowship ( APP1117940 ), respectively.
Publisher Copyright:
© 2022
PY - 2023/3
Y1 - 2023/3
N2 - Background: There are limited antimicrobial resistance (AMR) surveillance data from low- and middle-income countries, especially from the Pacific Islands region. AMR surveillance data is essential to inform strategies for AMR pathogen control. Methods: We performed a retrospective analysis of antimicrobial susceptibility results from the national microbiology laboratories of four Pacific Island countries – the Cook Islands, Kiribati, Samoa and Tonga – between 2017 and 2021. We focused on four bacteria that have been identified as ‘Priority Pathogens’ by the World Health Organization: Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa. Findings: Following deduplication, a total of 20,902 bacterial isolates was included in the analysis. The most common organism was E. coli (n = 8455) followed by S. aureus (n = 7830), K. pneumoniae (n = 2689) and P. aeruginosa (n = 1928). The prevalence of methicillin resistance among S. aureus isolates varied between countries, ranging from 8% to 26% in the Cook Islands and Kiribati, to 43% in both Samoa and Tonga. Ceftriaxone susceptibility remained high to moderate among E. coli (87%–94%) and K. pneumoniae (72%–90%), whereas amoxicillin + clavulanate susceptibility was low against these two organisms (50%–54% and 43%–61%, respectively). High susceptibility was observed for all anti-pseudomonal agents (83%–99%). Interpretation: Despite challenges, these Pacific Island laboratories were able to conduct AMR surveillance. These data provide valuable contemporary estimates of AMR prevalence, which will inform local antibiotic formularies, treatment guidelines, and national priorities for AMR policy. Funding: Supported by the National Health and Medical Research Council.
AB - Background: There are limited antimicrobial resistance (AMR) surveillance data from low- and middle-income countries, especially from the Pacific Islands region. AMR surveillance data is essential to inform strategies for AMR pathogen control. Methods: We performed a retrospective analysis of antimicrobial susceptibility results from the national microbiology laboratories of four Pacific Island countries – the Cook Islands, Kiribati, Samoa and Tonga – between 2017 and 2021. We focused on four bacteria that have been identified as ‘Priority Pathogens’ by the World Health Organization: Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa. Findings: Following deduplication, a total of 20,902 bacterial isolates was included in the analysis. The most common organism was E. coli (n = 8455) followed by S. aureus (n = 7830), K. pneumoniae (n = 2689) and P. aeruginosa (n = 1928). The prevalence of methicillin resistance among S. aureus isolates varied between countries, ranging from 8% to 26% in the Cook Islands and Kiribati, to 43% in both Samoa and Tonga. Ceftriaxone susceptibility remained high to moderate among E. coli (87%–94%) and K. pneumoniae (72%–90%), whereas amoxicillin + clavulanate susceptibility was low against these two organisms (50%–54% and 43%–61%, respectively). High susceptibility was observed for all anti-pseudomonal agents (83%–99%). Interpretation: Despite challenges, these Pacific Island laboratories were able to conduct AMR surveillance. These data provide valuable contemporary estimates of AMR prevalence, which will inform local antibiotic formularies, treatment guidelines, and national priorities for AMR policy. Funding: Supported by the National Health and Medical Research Council.
KW - Antibiotic resistance
KW - Antimicrobial
KW - Bacteriology
KW - Epidemiology
KW - Pacific islands
KW - Public health surveillance
UR - http://www.scopus.com/inward/record.url?scp=85149729138&partnerID=8YFLogxK
U2 - 10.1016/j.lanwpc.2022.100677
DO - 10.1016/j.lanwpc.2022.100677
M3 - Article
C2 - 36798514
AN - SCOPUS:85149729138
SN - 2666-6065
VL - 32
JO - The Lancet Regional Health - Western Pacific
JF - The Lancet Regional Health - Western Pacific
M1 - 100677
ER -